BiotechTube
Home/Tavanta Therapeutics/Dr. Andreas Maetzel
DA

Dr. Andreas Maetzel

Chief Medical Officer

Tavanta Therapeutics

Therapeutic Areas

OncologyColorectal CancerUro-oncology

Tavanta Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Colorectal Program(s)Colorectal CancerPhase 2
Undisclosed Uro-oncology Program(s)Uro-oncology (e.g., bladder, kidney, prostate cancers)Phase 2

Leadership Team at Tavanta Therapeutics

LP
Lynne Powell
Chief Executive Officer
DB
Darren Brayton
Vice President, Technical Operations
DE
Dr. Elizabeth Manning Duus
Vice President, Clinical Development
View full Tavanta Therapeutics profile